Jiménez HBA, Santos HJE, Acosta RCQ, Contreras CTI, Luévanos VA

Idioma: Español
Referencias bibliográficas: 25
Paginas: 29-32
Archivo PDF: 258.28 Kb.

RESUMEN

Las manifestaciones dermatológicas son un signo frecuente en el curso de la enfermedad por COVID-19, el síndrome de Gianotti-Crosti se observa como una manifestación posterior a la infección por SARS-COV-2, y se debe considerar como posible diagnóstico diferencial. Exponemos el caso de un paciente de 11 meses de edad que fue llevado a urgencias por fiebre de 39.9 °C, se diagnosticó como faringitis y enviado a su domicilio. Dos semanas después acudió a revaloración porque presentaba un exantema maculopapular de predominio en el tronco, las extremidades y el tórax anterior y posterior; las plantas y las palmas no estaban afectadas; se catalogó como enfermedad exantemática febril. Ante el contexto de pandemia por COVID-19 se tomó prueba rápida antigénica, con resultado no reactivo, y serologías para SARS-COV-2 igG positiva.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Marzano, A., Genovese, G., Fabbrocini, G. et al., “Varicella- like exanthem as a specific covid-19 associated skin manifestation: multicenter case series of 22 patients”, J Am Acad Dermatol, 2020, 83: 280-285.

2. Galván, C., Catal, A. y Carretero, G., “Classification of the cutaneous manifestations of covid-19: a rapid prospective nationwide consensus study in Spain with 375 cases”, Br J Dermatol, 2020, 183: 71-77.

3. Ahouach, B., Harant, S. y Ullmer, A., “Cutaneous lesions in a patient with covid-19: are they related?”, Br J Dermatol, 2020, 183 (2): e31.

4. Herrero-Moyano, M., Capusan, T.M., Andreu-Barasoain, M. et al., “A clinicopathological study of eight patients with covid-19 pneumonia and a late-onset exanthema”, J Eur Acad Dermatol Venereol, 2020, 34 (9): e460-e464.

5. Reymundo, A., Fernáldez, A., Reolid, A. et al., “Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients”, J Eur Acad Dermatol Venereol, 2020, 34 (12): e755-e757.

6. Mahe, A., Birckel, E., Krieger, S., Merklen, C. y Bottlaender, L., “A distinctive skin rash associated with coronavirus fisease 2019?”, J Eur Acad Dermatol Venereol, 2020, 34: 246-247.

7. Domínguez, M., Díaz, B., García, P. et al., “Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus sars-cov-2 infection (covid-19)”, J Eur Acad Dermatol Venereol, 2020, 34 (10): e536-e537.

8. Piccolo, V., Neri, I., Filippeschi, C. et al., “Chilblain-like lesions during covid-19 epidemic: a preliminary study on 63 patients”, J Eur Acad Dermatol Venereol, 2020, 34 (7): e291-e293.

9. Recalcati, S., Barbagallo, T. y Frasin, L.A., “Acral cutaneous lesions in the time of covid-19”, J Eur Acad Dermatol Venereol, 2020, 34: e212-e213.

10. Henry, D., Ackerman, M., Sancelme, E., Finon, A. y Esteve, E., “Urticarial eruption in covid-19 infection”, J Eur Acad Dermatol Venereol, 2020, 34: 244-245.

11. Torrelo, A., Andina, D., Santonja, C. et al., “Erythema multiforme-like lesions in children and covid-19”, Pediatr Dermatol, 2020, 37 (3): 442-446.

12. Gümüş, P., Tekşam, Ö., Akinci, H., Boztepe, G. y Kara, A., “Gianotti-Crosti syndrome as the only manifestation of primary Epstein-Barr virus infection: a case report”, Turk J Pediatr, 2008, 50: 302-304.

13. Chuh, A.A., “Diagnostic criteria for Gianotti-Crosti syndrome: a prospective case-control study for validity assessment”, Cutis, 2001, 68: 207-213.

14. Monastirli, A., Varvarigou, A., Pasmatzi, E., Badavanis, G., Georgiou, S., Mantagos, S. et al., “Gianotti-Crosti syndrome after hepatitis a vaccination”, Acta Derm Venereol, 2007, 8: 174-175.

15. Gibbs, S. y Burrows, N.P., “Gianotti-Crosti syndrome in two unrelated adults”, Clinical and Experimental Dermatology, 2000, 25: 594-596.

16. Murphy, L.A. y Buckley, C., “Gianotti-Crosti syndrome in an infant following immunization”, Pediatr Dermatol, 2000, 17: 225-226.

17. Boeck, K., Mempel, M., Schmidt, T. y Abeck, D., “Gianotti- Crosti syndrome: clinical, serologic, and therapeutic data from nine children”, Cutis, 1998, 62: 271.

18. Murphy, L.A. y Buckley, C., “Gianotti-Crosti syndrome in an infant following immunization”, Pediatr Dermatol, 2000, 17: 225-226.

19. Swali, R.N., Lee, E.B. y Adams, J.L., “Gianotti-Crosti syndrome in the setting of recent coronavirus disease-19 infection, Pediatr Dermatol, 2021, 00: 1-3.

20. Baldari, U., Monti, A. y Righini, M.G., “An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus”, Dermatology (Basilea), 1994, 188 (3): 203-204.

21. Kolivras, A. y André, J., “Gianotti-Crosti syndrome following hepatitis a vaccination”, Pediatr Dermatol, 2008, 25: 650.

22. Hyun, K.N., Eun, K.J., Kee, C.B. y Jeong, P.H., “Gianotti- Crosti syndrome following novel influenza a (h1n1) vaccination”, Ann Dermatol, 2011, 23: 554-555.

23. Erkek, E., Senturk, G.B., Özkaya, Ö. y Bükülmez, G., “Gianotti- Crosti syndrome preceded by oral polio vaccine and followed by varicella infection”, Pediatr Dermatol, 2001, 18: 516.

24. Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X. et al., “Clinical characteristics of coronavirus disease 2019 in China”, N Engl J Med, 2020, 382: 1708-1720.

25. Brandt, O. y Abeck, D., “Gianotti-Crosti syndrome”, J Am Acad Dermatol, 2006, 54: 136-145.